Effect of Cilostazol on Lipid, Uric Acid and Glucose Metabolism in Patients with Impaired Glucose Tolerance or Type 2 Diabetes Mellitus: A Double-Blind, Placebo-Controlled Study

By Toyota T.  

Clinical Drug Investigation, Vol. 21, Iss. 5, 2001-01 ,pp. : 325-335

Adis International

Access to resources Recommend Favorite

Combination lipid therapy in type 2 diabetes mellitus

By Vergèès Bruno  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Beneficial and Detrimental Effects of Intensive Glycaemic Control, with Emphasis on Type 2 Diabetes Mellitus

By Camacho P.  

Drugs & Aging, Vol. 17, Iss. 6, 2000-12 ,pp. : 463-476

Adis International

Access to resources Recommend Favorite

Fenofibrate: A Review of its Lipid-Modifying Effects in Dyslipidemia and its Vascular Effects in Type 2 Diabetes Mellitus

By Keating Gillian M.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 4, 2011-08 ,pp. : 227-247

Adis International

Access to resources Recommend Favorite

Comparison of the Effects of Policosanol and Atorvastatin on Lipid Profile and Platelet Aggregation in Patients with Dyslipidaemia and Type 2 Diabetes Mellitus

By Castaño G.  

Clinical Drug Investigation, Vol. 23, Iss. 10, 2003-01 ,pp. : 639-650

Adis International

Access to resources Recommend Favorite